Hi Everybody,
Been a steady I-hub board reader and Anavex investor (long) for the last 5 years. My sincere thanks to all those contributing in a positive, thoughtful and informative manner during all this time. You’ve kind of become my extended family, (so to speak), and always look forward every morning for my Anavex daily fix.
I am also a longtime subscriber to Tom Bishops’ BI Research Newsletter. He’s been highly rated for years and probably follows Anavex more closely than anybody I know of. I’m composing this post in order to give back to the board a little insight and share some comments he made which I came across not too long ago regarding Anavex Prospects at that time and compare it to today’s time.
It references slide 21 presented at this years Leerink Presentation, (can be found on the Anavex website). Believing this slide is the still the Key to the Anavex story and in one single slide, shows “Why you want to own this stock. Slide 21 shows graphically a 3 year Phase 2a Alzheimer’s study of Mini Mental State Exam (cognition) and ADL (Activities of Daily Living) scores during which those given the higher dose of AnaveX 2-73 showed very little decline in scores AFTER 3 YEARS (!) on these two key exams as compared to steep declines in the scores for those taking the lower dose which essentially acted as a placebo. Equally, if not more important, look at those P -Values! Though the study was relatively small and where a P-Value of .05 or lower is Considered Significant by the FDA, the MMSE data had a P- Value of.00008 (! not a typo) indicating a very high consistency of the results and therefore a low probability that these results are by chance And the ADL had an even better P-Value of .0001! While the study was relatively small, this is a phenomenal result!
Nothing approved on the market today can even come close to this result. If Anavex’s 1 year, 450 patient Phase 2/b. Alzheimer’s study currently finishing enrollment can even come close to this same result...away we go,
IMHO”
